← Open Payments lookup

SANDRA GAROFALO: Open Payments

NPI 1689221905 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$11,887 in 78 payments from 29 companies in 2025. Trend: 2023 $1,441 · 2024 $9,297 · 2025 $11,887

Speaker / faculty: $6,235Travel & lodging: $2,841Food & beverage: $2,649Long term medical supply or device loan: $83Education: $78
CompanyPaymentsAmount
JAZZ PHARMACEUTICALS INC.14$9,372
Janssen Biotech, Inc.4$371
Syndax Pharmaceuticals, Inc.3$313
Amgen Inc.2$282
Novartis Pharmaceuticals Corporation12$279
Incyte Corporation3$259
AstraZeneca Pharmaceuticals LP2$153
ABBVIE INC.6$137
SANOFI-AVENTIS U.S. LLC2$111
PFIZER INC.4$66

Products named: ZIIHERA, RYBREVANT, KISQALI, REVUFORJ, IMDELLTRA (AMG757), Monjuvi, BLINCYTO, Jakafi.

Industry payments across IN — which companies pay providers there.